[Effect of Prolixan 300 (Azapropazone) on the course of rheumatoid disease and degenerative joint disease. Comparison with indomethacin by means of a double blind test].
D000328:Adult; D000368:Aged; D001032:Apazone / Q000009:adverse effects / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D007213:Indomethacin / Q000009:adverse effects / Q000627:therapeutic use*; D007592:Joint Diseases / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D014227:Triazines / Q000627:therapeutic use*
D014227:Triazines; D001032:Apazone; D007213:Indomethacin
Wpływ Prolixanu 300 (Azapropazonu) na przebieg chofoby reumatoidalnej i choroby zwyrodnieniowej. Porównanie z wpływem indometacyny za pomoca podwójnie ślepej próby.